Company profilePharmaceutical#559 of 1,318 in Pakistan✓ No DRAP alerts

Oncogen Pharma (Pvt) Limited

Pharmaceutical company · 22 brands · 20 molecules

22 registered products 22 pharmaceutical brands 20 distinct molecules 0 DRAP alerts

Company overview

22
registered products
22
pharmaceutical brands
20
distinct molecules
0
therapeutic classes
0
DRAP alerts

Oncogen Pharma (Pvt) Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 22 product registrations across 20 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Oncogen

19 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

19
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202619

Top molecules by brand count

Lenalidomide3 brands
Paclitaxel3 brands
Capecitabine2 brands
Docetaxel2 brands
Abiraterone2 brands
Doxorubicin2 brands
Imatinib2 brands
Lenalidomide ...... 10 Mg1 brand
Lenalidomide ...... 5 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official28 products · Rs 763.54 – Rs 202,094.93
Median across source: Rs 26,169.49

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

AceclofenacBicalutamideBortezomibCarboplatinIrinotecan 20MgSevoflurane
AJ Mirza Pharma Pvt Ltd DSL: 235 holds 15 molecules not in this portfolio
AtorvastatinBovine Lipid Extract SurfactantEntecavirErlotinibFlutamideIohexol
HELIX PHARMA (PRIVATE) LIMITED holds 111 molecules not in this portfolio
000 I.UAmlodipineAmylaseArtemetherArtesunateAscorbic Acid

Get the full profile for Oncogen

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.